KLF2 and acute myeloid leukemia: Of note, 122/224 (54%) of group 1 enhancers were also co-occupied by FOXC1 and RUNX1 in primary AML cells (BB171) with strong binding close to genes such as KLF2, ID1, and MEF2C (Figures 4A and S5E).